TAZODIP™ is a broad-spectrum antibiotic combining Piperacillin, an extended-spectrum penicillin, with Tazobactam, a β-lactamase inhibitor. This powerful combination enhances efficacy against resistant bacteria, making it ideal for hospital-acquired infections and complicated bacterial conditions.
Extended-Spectrum Penicillin – Piperacillin disrupts bacterial cell wall synthesis, effectively killing bacteria.
β-Lactamase Inhibitor – Tazobactam prevents bacterial resistance, extending coverage to drug-resistant pathogens.
Strong Activity Against ESBL Pathogens – Effective against E. coli, Pseudomonas, Klebsiella, and Enterobacter.
Why Choose TAZODIP™?
Broad-Spectrum Bactericidal Action – Effective against a wide range of bacteria.
Prevents Resistance Development – Tazobactam protects Piperacillin from bacterial degradation.
Ideal for Severe Hospital-Acquired Infections – Used in sepsis, pneumonia, UTIs, and intra-abdominal infections.
Excellent Safety Profile – Well-tolerated with low side effects.
Reduces Hospital Stay – Ensures faster infection clearance for quicker patient recovery.
Indications
Severe Lower Respiratory Tract Infections – Treats hospital-acquired pneumonia (HAP & VAP) and aspiration pneumonia.
Complicated Urinary Tract Infections (UTIs) – Covers ESBL-producing E. coli, Klebsiella, and Pseudomonas.
Intra-Abdominal Infections – Effective for peritonitis, abscesses, appendicitis, and biliary infections.
Sepsis & Bloodstream Infections – Broad-spectrum action against bacteremia and septicemia.
Skin & Soft Tissue Infections – Treats diabetic foot infections, cellulitis, and necrotizing fasciitis.
Gynecological Infections – Used in pelvic inflammatory disease (PID) and postpartum infections.
Dosage & Administration
Recommended Dosage:
Standard Dose: 4.5 g IV every 8 hours for 7-14 days, or as prescribed.
For Severe Infections: 4.5 g IV every 6 hours in critically ill patients.
Administration:
Administer via slow IV infusion (30 minutes).
Adjust dose in renal impairment to prevent drug accumulation.
Complete the full course to prevent bacterial resistance.
Precautions & Warnings
Do Not Use in Patients with Penicillin Allergy – Risk of hypersensitivity reactions.
Caution in Renal Disease – Requires dose adjustment in kidney impairment.
May Cause Mild Side Effects – Includes nausea, diarrhea, headache, or rash.
Avoid Concurrent Use with Aminoglycosides – May cause antibiotic inactivation.
Monitor Liver & Kidney Function – Long-term use may affect organ function.
Seek immediate medical help for severe allergic reactions, seizures, or persistent diarrhea.
TAZODIP™ (Piperacillin 4 g + Tazobactam 0.5 g) is a potent broad-spectrum antibiotic designed to combat severe, hospital-acquired infections. With enhanced activity against multidrug-resistant bacteria, it ensures rapid bacterial eradication, faster recovery, and reduced hospital stays.
Broad-Spectrum Coverage | ESBL-Effective | Trusted Hospital Antibiotic
FIGHT SEVERE INFECTIONS WITH TAZODIP™ – ADVANCED ANTIBIOTIC
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category Anti Bacterials
You can also contact us www.dakshpharma.com/contact-us
